These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Parent and child perception of quality of life in a randomized controlled peanut oral immunotherapy trial. Reier-Nilsen T; Carlsen KCL; Michelsen MM; Drottning S; Carlsen KH; Zhang C; Borres MP; Håland G Pediatr Allergy Immunol; 2019 Sep; 30(6):638-645. PubMed ID: 31013372 [TBL] [Abstract][Full Text] [Related]
10. A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients. Schneider LC; Rachid R; LeBovidge J; Blood E; Mittal M; Umetsu DT J Allergy Clin Immunol; 2013 Dec; 132(6):1368-74. PubMed ID: 24176117 [TBL] [Abstract][Full Text] [Related]
11. Oral peanut immunotherapy in children with peanut anaphylaxis. Blumchen K; Ulbricht H; Staden U; Dobberstein K; Beschorner J; de Oliveira LC; Shreffler WG; Sampson HA; Niggemann B; Wahn U; Beyer K J Allergy Clin Immunol; 2010 Jul; 126(1):83-91.e1. PubMed ID: 20542324 [TBL] [Abstract][Full Text] [Related]
12. Peanut Oral Immunotherapy With or Without H Chu DK; Freitag T; Marrin A; Walker TD; Avilla E; Freitag A; Spill P; Foster GA; Thabane L; Jordana M; Waserman S J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2386-2394. PubMed ID: 35643280 [TBL] [Abstract][Full Text] [Related]
13. Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions. Wasserman RL; Factor JM; Baker JW; Mansfield LE; Katz Y; Hague AR; Paul MM; Sugerman RW; Lee JO; Lester MR; Mendelson LM; Nacshon L; Levy MB; Goldberg MR; Elizur A J Allergy Clin Immunol Pract; 2014; 2(1):91-6. PubMed ID: 24565775 [TBL] [Abstract][Full Text] [Related]
14. First Real-World Safety Analysis of Preschool Peanut Oral Immunotherapy. Soller L; Abrams EM; Carr S; Kapur S; Rex GA; Leo S; Lidman PG; Yeung J; Vander Leek TK; McHenry M; Wong T; Cook VE; Hildebrand KJ; Gerstner TV; Mak R; Lee NJ; Cameron SB; Chan ES J Allergy Clin Immunol Pract; 2019; 7(8):2759-2767.e5. PubMed ID: 31002957 [TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy and immune regulation with peanut oral immunotherapy. Jones SM; Pons L; Roberts JL; Scurlock AM; Perry TT; Kulis M; Shreffler WG; Steele P; Henry KA; Adair M; Francis JM; Durham S; Vickery BP; Zhong X; Burks AW J Allergy Clin Immunol; 2009 Aug; 124(2):292-300, 300.e1-97. PubMed ID: 19577283 [TBL] [Abstract][Full Text] [Related]
16. Low dose immunotherapy in very young children to treat peanut allergy. Vickery BP Expert Rev Clin Immunol; 2016 Dec; 12(12):1251-1253. PubMed ID: 27599211 [No Abstract] [Full Text] [Related]
17. Peanut Oral Immunotherapy: a Current Perspective. Patrawala M; Shih J; Lee G; Vickery B Curr Allergy Asthma Rep; 2020 Apr; 20(5):14. PubMed ID: 32314071 [TBL] [Abstract][Full Text] [Related]
18. Oral Immunotherapy in Japanese Children with Anaphylactic Peanut Allergy. Nagakura KI; Sato S; Yanagida N; Nishino M; Asaumi T; Ogura K; Ebisawa M Int Arch Allergy Immunol; 2018; 175(3):181-188. PubMed ID: 29339650 [TBL] [Abstract][Full Text] [Related]
19. Current opinion and review on peanut oral immunotherapy. Deol S; Bird JA Hum Vaccin Immunother; 2014; 10(10):3017-21. PubMed ID: 25483680 [TBL] [Abstract][Full Text] [Related]
20. Safety of a peanut oral immunotherapy protocol in children with peanut allergy. Hofmann AM; Scurlock AM; Jones SM; Palmer KP; Lokhnygina Y; Steele PH; Kamilaris J; Burks AW J Allergy Clin Immunol; 2009 Aug; 124(2):286-91, 291.e1-6. PubMed ID: 19477496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]